CMC Considerations for Developing an Effective mRNA/LNP Therapeutic

แชร์
ฝัง
  • เผยแพร่เมื่อ 22 ก.ย. 2024
  • Dr. Akhilesh Bhambhani, Sr. Director of Biologics Drug Product Development at Ultragenyx discusses CMC Considerations for developing an effective mRNA/LNP therapeutic.
    Learn more about microfluidic technology: www.precisionn...
    Follow us on LinkedIn: bit.ly/3F9uEiL
    Follow us on Twitter: bit.ly/3yBttpW

ความคิดเห็น •